131 related articles for article (PubMed ID: 6947950)
21. Elevated concentrations of soluble adhesion molecules and large platelets in diabetic patients: are they markers of vascular disease and diabetic nephropathy?
Bavbek N; Kargili A; Kaftan O; Karakurt F; Kosar A; Akcay A
Clin Appl Thromb Hemost; 2007 Oct; 13(4):391-7. PubMed ID: 17911190
[TBL] [Abstract][Full Text] [Related]
22. Coagulation in diabetic and non-diabetic claudicants.
Gosk-Bierska I; Adamiec R; Alexewicz P; Wysokinski WE
Int Angiol; 2002 Jun; 21(2):128-33. PubMed ID: 12110772
[TBL] [Abstract][Full Text] [Related]
23. Secretion of growth hormone in the insulin test, and the development of diabetic microangiopathy.
Sieradzki J
Pol Med Sci Hist Bull (1973); 1976; 15(2):191-6. PubMed ID: 959044
[TBL] [Abstract][Full Text] [Related]
24. Relationship between autonomic function and plasma fibrinogen, viscosity, and elements of fibrinolytic activity in diabetic nephropathy.
Weinrauch LA; Gleason RE; Keough J; D'Elia JA
Am J Hypertens; 1997 Apr; 10(4 Pt 1):454-61. PubMed ID: 9128213
[TBL] [Abstract][Full Text] [Related]
25. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[TBL] [Abstract][Full Text] [Related]
26. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
27. [Fibrinogen and diabetic microangiopathy].
Mojto V
Vnitr Lek; 1997 Feb; 43(2):81-6. PubMed ID: 9245073
[TBL] [Abstract][Full Text] [Related]
28. [Hemostatic function in diabetes mellitus and hyperlipoproteinemia].
Zöller H; Schott G; Gross W
Med Klin; 1978 Dec; 73(49):1715-23. PubMed ID: 723758
[No Abstract] [Full Text] [Related]
29. Von Willebrand factor in diabetic angiopathy.
Kessler L; Wiesel ML; Attali P; Mossard JM; Cazenave JP; Pinget M
Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
[TBL] [Abstract][Full Text] [Related]
30. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
31. [Hemostatic balance during treatment with the newest contraceptives].
Petersen KR; Skouby SO; Sidelmann J; Jespersen J
Ugeskr Laeger; 1994 Jan; 156(2):187-90. PubMed ID: 8296409
[TBL] [Abstract][Full Text] [Related]
32. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
[TBL] [Abstract][Full Text] [Related]
33. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
[TBL] [Abstract][Full Text] [Related]
34. Hemostasis and atherosclerosis.
Warkentin TE
Can J Cardiol; 1995 May; 11 Suppl C():29C-34C. PubMed ID: 7750046
[TBL] [Abstract][Full Text] [Related]
35. Possible involvement of Von Willebrand factor in pancreatic graft thrombosis after kidney-pancreas transplantation: a retrospective study.
Kessler L; Wiesel ML; Boudjema K; Lutun E; Moulin B; Cazenave JP; Wolf P; Pinget M
Clin Transplant; 1998 Feb; 12(1):35-42. PubMed ID: 9541421
[TBL] [Abstract][Full Text] [Related]
36. Increased platelet aggregation in diabetic patients with microangiopathy despite good glycemic control.
Kajita K; Ishizuka T; Miura A; Kanoh Y; Ishizawa M; Kimura M; Yasuda K
Platelets; 2001 Sep; 12(6):343-51. PubMed ID: 11672473
[TBL] [Abstract][Full Text] [Related]
37. [Some parameters of hemostasis and fibrinolysis in diabetic patients].
Telejko B; Zonenberg A; Borejszo I; Kinalska I
Pol Arch Med Wewn; 1998 Aug; 100(2):133-8. PubMed ID: 10101928
[TBL] [Abstract][Full Text] [Related]
38. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
39. [State of the microcirculatory component of hemostasis and microhemodynamics in patients with diabetic angiopathies].
Petrova TR; Pavlishchuk SA; Vil'chinskaia MN
Ter Arkh; 1984; 56(8):129-32. PubMed ID: 6495194
[TBL] [Abstract][Full Text] [Related]
40. Diabetes mellitus, vascular disease and thrombosis.
Banga JD; Sixma JJ
Clin Haematol; 1986 May; 15(2):465-92. PubMed ID: 3524933
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
